Contents
Download PDF
pdf Download XML
12 Views
1 Downloads
Share this article
Case Report | Volume 6 Issue 1 (January-February, 2026) | Pages 13 - 17
Integrative Yoga Prana Vidya (YPV)Healing Support in Treatment of Recurrent Liver Tumor with Cirrhosis and Hepatitis B: A case study
 ,
1
Certified YPV and level 5 Healer, Trainer YPV Level 2&3, Ujjain (MP), India
2
Consultant, Research & Publications, YPV Ashram, Sri Ramana Trust, Thally-635118, Tamil Nadu, India
Under a Creative Commons license
Open Access
Received
Nov. 10, 2025
Revised
Dec. 6, 2025
Accepted
Dec. 20, 2025
Published
Jan. 15, 2026
Abstract

Background:Chronic Hepatitis B infection is a known precursor to liver cirrhosis and hepatocellular carcinoma(HCC). Recurrent hepatic tumors pose significant physical and emotional challenges. This case explores the role of Yoga Prana Vidya (YPV) healing as a complementary intervention in a patient with recurrent liver tumors and cirrhosis.

Case Presentation:A 60-year-old male with lifelong Hepatitis B and cirrhosis developed hepatic tumors in April 2024, September 2024, and January 2025, each surgically removed via microwave ablation (MWA). Following the third recurrence, the patient experienced emotional distress and was introduced to YPV healing in April 2025. A Certified YPV and Level 5 healer initiated daily sessions, later joined by a Certified Senior YPV and Level 6 healer for intensive three-times-daily healing from May to July 2025. The protocol included YPV Level 5 and 6 techniques, blood and organ cleansing, psychotherapy, and environmental energy hygiene. The patient also practiced daily salt water baths, breathing exercises, forgiveness sadhana, and weekly Planetary Peace Meditation from YPV Sadhana App.

Outcomes:MRI and blood tests conducted on 29 July 2025 and again on 01 November 2025 showed no new tumor formation and normalized parameters. The patient reported improved energy, emotional stability, and resolution of minor ailments without medication.

Conclusion:This case suggests that YPV healing may offer valuable adjunctive support in managing chronic hepatic conditions, enhancing emotional resilience, and potentially contributing to tumor non-recurrence. Further clinical studies are warranted to explore its integrative potential in oncology and chronic disease care.

Keywords
Recommended Articles
Research Article
Evaluation of SARS-CoV-2 antibody titres following Covid vaccination in HIV patients on Antiretroviral therapy: An Observational study
...
Published: 12/01/2026
Download PDF
Read Article
Research Article
Immediate Implants in Extraction Sockets with Peri-apical Lesions: A Prospective controlled Study
...
Published: 02/01/2026
Download PDF
Read Article
Research Article
Download PDF
Read Article
Review Article
RECENT TRENDS AND CHALLENGES IN DRUG DESIGN: A REVIEW
Published: 09/11/2025
Download PDF
Read Article
Chat on WhatsApp
© Copyright IASR